Highnoon inks deal with Acino


KARACHI – Acino Pharma of Switzerland, a company specialising in the development of advanced pharmaceutical formulations in the fields of oncology, acute pain management and palliative care, has concluded an agreement with Highnoon Laboratories Limited to make its product portfolio available in Pakistan. Highnoon Laboratories Limited is a leading corporation dealing in high quality prescription drugs in Pakistan and manufacturing drugs under license for several world renowned companies for the last 26 years.
In Lahore, Regional Director Asia Business for Acino Pharma Asia Salman Bokhari held detailed discussions with Highnoon Laboratories Limited Chairman Tausif Ahmad Khan and the senior management to finalise arrangements to make available the Acino Pharma brands in Pakistan.